Literature DB >> 10548472

Confirmation of the rat model of chronic, moderately elevated intraocular pressure.

A Sawada1, A H Neufeld.   

Abstract

We have confirmed the usefulness of the rat model of chronic, moderately elevated intraocular pressure (IOP) for studying loss of retinal ganglion cells, and as a model for pharmacological neuroprotection studies that may be relevant to treating human glaucoma. By unilaterally cauterizing three episcleral vessels, as described previously in the literature by another laboratory, we observed an approximately 1.6-fold increase in IOP compared to the contralateral eye (18.6 vs 11.5 mm Hg, respectively). Elevated IOP persisted for 6 months without re-treatment. Cupping of the optic disk was observable by examination, in vivo. In 6 months, there was an approximately 40% loss of retinal ganglion cells in the peripheral retina. This model provides a reproducible and quantitative model for pharmacological experiments using neuroprotective agents. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10548472     DOI: 10.1006/exer.1999.0732

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  33 in total

1.  A mouse model of elevated intraocular pressure: retina and optic nerve findings.

Authors:  Ronald L Gross; Jianzhong Ji; Peter Chang; Mark E Pennesi; Zhuo Yang; Jian Zhang; Samuel M Wu
Journal:  Trans Am Ophthalmol Soc       Date:  2003

2.  En face optical coherence tomography: a new method to analyse structural changes of the optic nerve head in rat glaucoma.

Authors:  L Guo; V Tsatourian; V Luong; A G Podoleanu; A G Podolean; D A Jackson; F W Fitzke; M F Cordeiro
Journal:  Br J Ophthalmol       Date:  2005-09       Impact factor: 4.638

3.  The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice.

Authors:  Rebecca M Sappington; Brian J Carlson; Samuel D Crish; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

Review 4.  Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressure.

Authors:  John C Morrison; William O Cepurna; Elaine C Johnson
Journal:  Exp Eye Res       Date:  2015-05-21       Impact factor: 3.467

5.  Imaging apoptosis in the eye.

Authors:  M F Cordeiro; C Migdal; P Bloom; F W Fitzke; S E Moss
Journal:  Eye (Lond)       Date:  2011-03-25       Impact factor: 3.775

6.  Differential susceptibility to experimental glaucoma among 3 mouse strains using bead and viscoelastic injection.

Authors:  Frances E Cone; Scott E Gelman; Janice L Son; Mary E Pease; Harry A Quigley
Journal:  Exp Eye Res       Date:  2010-06-26       Impact factor: 3.467

7.  Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia.

Authors:  Akira Hirata; Masaru Inatani; Yasuya Inomata; Naoko Yonemura; Takahiro Kawaji; Megumi Honjo; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-31       Impact factor: 3.117

8.  Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model.

Authors:  John Danias; Fran Shen; Manolis Kavalarakis; Bin Chen; David Goldblum; Kevin Lee; Maria-Florencia Zamora; YanLing Su; Scott E Brodie; Steven M Podos; Thom Mittag
Journal:  Exp Eye Res       Date:  2005-08-16       Impact factor: 3.467

Review 9.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

Review 10.  Neurotrophin roles in retinal ganglion cell survival: lessons from rat glaucoma models.

Authors:  Elaine C Johnson; Ying Guo; William O Cepurna; John C Morrison
Journal:  Exp Eye Res       Date:  2009-02-14       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.